SAVANNAH: Safety and tolerability of osimertinib (osi) plus savolitinib (savo) in EGFRm advanced NSCLC with MET overexpression and/or amplification (OverExp/Amp) following disease progression on osi
Chu, Q. S. C.;
De Marinis, F.;
Levy, B.;
Bonanno, L.;
Cheng, S.;
외 15명
Citations
WEB OF SCIENCE
0
제목
SAVANNAH: Safety and tolerability of osimertinib (osi) plus savolitinib (savo) in EGFRm advanced NSCLC with MET overexpression and/or amplification (OverExp/Amp) following disease progression on osi
저자
Chu, Q. S. C.; De Marinis, F.; Levy, B.; Bonanno, L.; Cheng, S.; Sacher, A.; Proto, C.; Novello, S.; Luo, Y-H; Baik, C. S.; Bazhenova, L.; Yang, C. T.; Shimizu, J.; Riess, J. W.; Leventakos, K.; Nelson, S.; Igwegbe, I.; Haskins, M.; Xu, W.; Ahn, M-J